Skip to main content
UniHealth

Doctor search

Catherine C Arima, NP

Nurse Practitioner · Stanford

NPI 1700146487

Medicare standing
2 flags on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Offices
2

On the public record

  • California licence: Non-Completion of Probation
  • 1 Medical Board action on record

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Catherine C Arima’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence G18851 · Cancelled

Licence status: Cancelled · since 1970 · University of Miami School of Medicine. Board flags: Non-Completion of Probation.

License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.

Matched on the licence number without its letter prefix; check the name before relying on it.

Public record actions

Actions the Medical Board of California publishes for this licence
1991-09-12Board disciplineDisciplineEffective 11/20/72 license revoked; effective 09/12/91 license reinstated and placed on five years probation with various terms and conditions. · 04 1992020272

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$30,049

Medicare paid this office $30,049 for 293 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)214$15,882$57
Instillation of anti-cancer drug into bladder34$5,164$30
Insertion of lower leg neurostimulator electrode15$3,473$21
New patient visit (45+ min)15$1,698$113
Return visit (30+ min)12$927$77
See all 6 services
Every Original Medicare service billed
Short return visit (20+ min)214$15,882$57
Instillation of anti-cancer drug into bladder34$5,164$30
Insertion of lower leg neurostimulator electrode15$3,473$21
New patient visit (45+ min)15$1,698$113
Return visit (30+ min)12$927$77
Insertion of temporary bladder tube17$638$18

Who their Medicare patients are

293 Original Medicare patients in 2024. Average age 76 · Women 27% · Also on Medicaid 11% · Health risk score 1.33. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 72% · Cancer 40% · Chronic kidney disease 30% · Diabetes 29% · Coronary heart disease 27% · Atrial fibrillation 21% · Depression 21% · Heart failure 13% · COPD 10% · Stroke 10% · Dementia 8%.

The office billed $267,505, Medicare allowed $41,182 and paid $30,049; for 733 services of 18 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024293733761.33$267,505$30,049
2023262716751.36$221,396$24,906
2022206644761.43$183,612$20,714
2021142601751.27$162,214$17,866
2020117360741.29$104,903$10,254
2019133477751.45$132,940$15,010
201894645741.48$175,707$21,425
201775226751.40$59,332$8,784
2016102171741.60$16,895$5,491

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Short return visit (20+ min)189$11,153$45
Insertion of lower leg neurostimulator electrode25$5,716$21
Instillation of anti-cancer drug into bladder34$4,225$30
Return visit (30+ min)25$1,888$73

2022: 4 services

Original Medicare services billed in 2022
Short return visit (20+ min)147$8,645$45
Insertion of lower leg neurostimulator electrode28$6,265$21
Instillation of anti-cancer drug into bladder17$3,044$31
Return visit (30+ min)18$1,360$76

2021: 4 services

Original Medicare services billed in 2021
Insertion of lower leg neurostimulator electrode28$7,185$22
Short return visit (20+ min)88$5,428$47
Instillation of anti-cancer drug into bladder19$3,303$28
Insertion of temporary bladder tube11$270$19

2020: 4 services

Original Medicare services billed in 2020
Instillation of anti-cancer drug into bladder17$3,140$34
Insertion of lower leg neurostimulator electrode18$2,437$21
Short return visit (20+ min)53$2,219$33
Short return visit33$902$20

2019: 4 services

Original Medicare services billed in 2019
Short return visit (20+ min)93$6,066$35
Insertion of lower leg neurostimulator electrode21$3,397$21
Instillation of anti-cancer drug into bladder19$2,584$28
New patient visit (45+ min)18$1,483$82

2018: 5 services

Original Medicare services billed in 2018
Short return visit (20+ min)63$9,788$36
Insertion of lower leg neurostimulator electrode20$4,263$21
Instillation of anti-cancer drug into bladder14$4,136$39
New patient visit (45+ min)16$1,312$82
Electronic assessment of bladder emptying11$40$4

2017: 6 services

Original Medicare services billed in 2017
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies17$1,531$90
Short return visit (20+ min)14$1,326$38
Insertion of device into abdomen with pressure and urine flow rate study15$452$30
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings17$239$14
Short return visit (20+ min)19$185$9
Electronic assessment of bladder emptying19$66$3

2016: 3 services

Original Medicare services billed in 2016
Short return visit (20+ min)79$3,447$34
Simple bladder irrigation and/or instillation14$1,284$34
Insertion of temporary bladder tube13$575$21

Drugs they prescribed that Part D paid

$104,055

Pharmacies billed $104,055 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

402 generic and fewer than 11 brand-name prescriptions · $104,055 in drug cost · 40 antibiotic prescriptions to 30 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Myrbetriq55$55,999$1,018
Gemtesa44$37,823$860
Tamsulosin154$3,745$24
Finasteride80$1,449$18
Alfuzosin Hcl Er29$604$21
See all 9 drugs
Every Part D drug this clinician prescribed
Myrbetriq55$55,999$1,018
Gemtesa44$37,823$860
Tamsulosin154$3,745$24
Finasteride80$1,449$18
Alfuzosin Hcl Er29$604$21
Tadalafil16$275$17
Doxazosin Mesylate15$270$18
Oxybutynin Chloride Er13$199$15
Hydrocortisone11$76$7

Year by year

Part D prescribing by year
2024504156NoneNone$104,055
20233651010% (0)22%$72,565
2022288103None13%$38,890
202121170NoneNone$21,750
202022371NoneNone$29,785
201921668None30%$36,923
201815851NoneNone$10,112
201714348None9%$7,979
201618486NoneNone$7,437
20158334None24%$4,092

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 7 drugs

Part D drugs prescribed in 2023
Myrbetriq68$58,720$864
Tamsulosin105$3,559$34
Methenamine Hippurate14$1,625$116
Finasteride49$910$19
Alfuzosin Hcl Er26$799$31
Doxazosin Mesylate16$475$30
Tadalafil17$307$18

2022: 5 drugs

Part D drugs prescribed in 2022
Myrbetriq33$31,391$951
Tamsulosin107$3,280$31
Alfuzosin Hcl Er29$588$20
Finasteride34$442$13
Tadalafil15$116$8

2021: 5 drugs

Part D drugs prescribed in 2021
Myrbetriq21$16,160$770
Tamsulosin76$2,363$31
Oxybutynin Chloride Er20$684$34
Alfuzosin Hcl Er24$622$26
Finasteride36$587$16

2020: 5 drugs

Part D drugs prescribed in 2020
Myrbetriq26$23,082$888
Tamsulosin73$2,297$31
Oxybutynin Chloride Er23$1,101$48
Finasteride48$1,048$22
Alfuzosin Hcl Er14$148$11

2019: 4 drugs

Part D drugs prescribed in 2019
Myrbetriq52$29,154$561
Oxybutynin Chloride Er30$993$33
Finasteride45$778$17
Tamsulosin26$590$23

2018: 5 drugs

Part D drugs prescribed in 2018
Myrbetriq13$6,968$536
Oxybutynin Chloride Er29$1,044$36
Tamsulosin25$538$22
Finasteride19$136$7
Ciprofloxacin12$69$6

2017: 2 drugs

Part D drugs prescribed in 2017
Tamsulosin61$1,351$22
Finasteride26$466$18

2016: 4 drugs

Part D drugs prescribed in 2016
Tamsulosin47$972$21
Finasteride34$540$16
Doxazosin Mesylate13$172$13
Ciprofloxacin15$105$7

Money from drug and device companies

$131 in 2024

Industry payments by year
202445None$131
202323None$52
202211None$20

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Valencia TechnologiesEcoin Device Kit$59
2 payments
  • Meals for Ecoin Device Kit · 2024-03-21 · $26
  • Meals for Ecoin Device Kit · 2024-02-07 · $33
EisaiLenvima$29
1 payment
  • Meals for Lenvima · 2024-11-12 · $29
Merck Sharp & DohmeKeytruda$27
1 payment
  • Meals for Keytruda · 2024-10-16 · $27
PfizerXtandi$17
1 payment
  • Meals for Xtandi · 2024-01-25 · $17
See all 5 published payments
Every published payment
EisaiMeals · 2024-11-12Lenvima$29
Merck Sharp & DohmeMeals · 2024-10-16Keytruda$27
Valencia TechnologiesMeals · 2024-03-21Ecoin Device Kit$26
Valencia TechnologiesMeals · 2024-02-07Ecoin Device Kit$33
PfizerMeals · 2024-01-25Xtandi$17
See earlier years (2023, 2022)

2023: $52

Payments by company in 2023
PfizerXtandi$35
2 payments
  • Meals for Xtandi · 2023-08-31 · $18
  • Meals for Xtandi · 2023-04-17 · $18
UroGen PharmaNone$17
1 payment
  • Meals · 2023-02-21 · $17

2022: $20

Payments by company in 2022
UroGen PharmaJelmyto$20
1 payment
  • Meals for Jelmyto · 2022-06-30 · $20

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1700146487
Licence
CA NP 18851California G18851: Cancelled
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 363LF0000X (363LF0000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2012-05-29
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.